Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/1995
06/20/1995US5426181 DNA encoding cytokine-induced protein, TSG-14
06/20/1995US5426100 Therapeutic uses including antitumor agents, anticoagulants and wound healing agents
06/20/1995US5426048 DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor
06/20/1995US5426046 Human monoclonal antibody to lipid A of gram negative bacteria
06/20/1995US5426044 Minactivin compositions and antibodies to minactivin
06/20/1995US5426029 Therapeutic and diagnostic methods using leukocyte surface antigens
06/20/1995US5425942 Giant protein complex; useful in screening for cancer
06/20/1995US5425937 Hair treatment composition and hair care product, both containing anti-keratin antibody, and production of anti-keratin antibody
06/16/1995CA2137640A1 Anti-idiotypic antibody having correspondence with human hepatitis b surface antigen
06/15/1995WO1995016206A1 Composition and method for detection of analytes
06/15/1995WO1995016205A1 Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
06/15/1995WO1995016038A2 Humanized antibodies and uses thereof
06/15/1995WO1995016037A1 Anti-egf-r/anti-cd3 bispecific monoclonal antibody, method for its production and its use
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995016027A1 Method of selecting specific bacteriophages
06/15/1995WO1995016026A1 Reagents and methods for the detection of methotrexate
06/15/1995WO1995015982A2 Process for generating specific antibodies
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015978A1 Pretargeting methods and compounds
06/15/1995WO1995015977A1 Peptide representing antigenic epitopes of feline ige present on feline b-cells but not feline basophil cell surfaces
06/15/1995WO1995015976A1 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
06/15/1995WO1995015769A1 Preparation and use of immunoconjugates
06/15/1995WO1995015764A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995WO1995006129A3 Transfection process
06/15/1995CA2178622A1 Humanized antibodies and uses thereof
06/15/1995CA2178590A1 Reagents and methods for the detection of methotrexate
06/15/1995CA2178477A1 Pretargeting methods and compounds
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2178205A1 Method of selecting specific bacteriophages
06/15/1995CA2177464A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/15/1995CA2175482A1 Process for generating specific antibodies
06/14/1995EP0657538A2 Process to produce engineered antibodies in plants, engineered antibodies and use thereof in diagnostics and therapeutics
06/14/1995EP0657536A1 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding
06/14/1995EP0657533A1 Monoclonal antibodies with high cytotoxicity against the human CD16 antigen, and bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody
06/14/1995EP0657532A1 HIV-3 retrovirus strains and their use
06/14/1995EP0657471A1 Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours
06/14/1995EP0657470A2 Monoclonal antibodies against in vivo glycated albumin
06/14/1995EP0657469A1 L-Selectin cleavage site, methods of diagnosis and usage thereof
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657175A2 Vaccine comprising autologous epidermal growth factor and use thereof
06/14/1995EP0656947A1 Human interleukin-13
06/14/1995EP0656946A1 Immunoglobulins devoid of light chains
06/14/1995EP0656945A1 Stress protein epitopes
06/14/1995EP0656944A1 Human melanocyte stimulating hormone receptor
06/14/1995EP0656941A1 Methods for producing members of specific binding pairs
06/14/1995EP0656908A1 Use of specific binding molecules in potentiating igf-i activity
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656789A1 Method for treating a lfa-1-mediated disorder
06/14/1995EP0583352A4 -i(IN VITRO) METHODS FOR DETERMINING -i(IN VIVO) THROMBOTIC EVENTS.
06/14/1995EP0494260B1 Granulocyte-colony stimulating factor receptors
06/14/1995EP0458841B1 Method for the use and synthesis of peptides
06/13/1995US5424400 Senescent cell derived inhibitors of DNA synthesis
06/13/1995US5424399 Recombinant heterodimer comprising extracellular domains of human complement receptor type 3 alpha and beta; inhibits CR3-mediated immune response
06/13/1995US5424398 A polypeptide supporting with a solid as antibody inhibitor
06/13/1995US5424221 Containing reactive poly- or monoclonal antibodies
06/13/1995US5424205 Complexing metalloprotease with an inhibitor, then exposure to an amyloid and monitoring to detect cleavage of methionine-aspartic acid bond
06/13/1995US5424066 Method for increasing CD4+ cell numbers through the use of monoclonal antibodies directed against self-reactive, CD4 specific cytotoxic T-cells
06/13/1995CA1335879C Receptor membranes
06/09/1995EP0724646A4 Dna sequences related to isolated fragile x syndrome
06/08/1995WO1995015497A1 Immunoassay for cervical cancer
06/08/1995WO1995015495A1 Prenatal detection of meconium
06/08/1995WO1995015396A1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a
06/08/1995WO1995015393A1 Novel expression screening vector
06/08/1995WO1995015388A1 Recombinant binding proteins and peptides
06/08/1995WO1995015386A1 Novel receptor tyrosine kinase
06/08/1995WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995WO1995015382A1 Binding structures directed against the ca55.1 antigen
06/08/1995WO1995015377A1 Plant arabinogalactan protein (agp) genes
06/08/1995WO1995015373A2 Inhibition of dna methyltransferase
06/08/1995WO1995015341A1 Antibody against carcinoembryonic antigen (cea)
06/08/1995WO1995015340A1 Monoclonal antibodies to antigens expressed by human dendritic cells
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
06/08/1995WO1995015338A1 Chaperonin 10
06/08/1995WO1995015331A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF
06/08/1995WO1995015181A1 Reperfusion therapy using antibodies to l-selectin
06/08/1995WO1995015180A1 Antibodies that mimic actions of neurotrophins
06/08/1995WO1995015179A1 Method of treating intestinal disorders
06/08/1995WO1995015178A1 Vibrio cholerae bengal serogroup-0139 capsular polysaccharide, protein conjugates thereof and antibodies induced thereby
06/08/1995WO1995015175A1 Galectin-8 and galectin-8-like proteins and dna molecules coding therefor
06/08/1995WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
06/08/1995WO1995015084A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
06/08/1995WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin
06/08/1995WO1995002054A3 Platelet glycoprotein v gene and uses
06/08/1995WO1994027556A3 Animal model for hepatitis virus infection
06/08/1995CA2177991A1 A 46 kd human milk fat globule antigen
06/08/1995CA2177988A1 Expression vector for preparing an anti-body-variable-region library
06/08/1995CA2177957A1 Specific fusion nucleic acids and proteins present in human t(2;5) lymphoma, methods of detection and uses thereof
06/08/1995CA2177953A1 Plant arabinogalactan protein (agp) genes
06/08/1995CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995CA2177584A1 Antibody against carcinoembryonic antigen (cea)
06/08/1995CA2177570A1 Method of treating intestinal disorders
06/08/1995CA2177367A1 Recombinant binding proteins and peptides
06/08/1995CA2177031A1 Inhibition of dna methyltransferase
06/08/1995CA2174972A1 Binding structures directed against the ca55.1 antigen
06/07/1995EP0656367A1 Method and composition for cancer therapy and for prognosticating responses to cancer theraphy
06/07/1995EP0656121A1 Method for diagnosing and monitoring sepsis
06/07/1995EP0656114A1 Method of determining metastatic potential of tumor cells
06/07/1995EP0656069A1 Inhibitors of cell proliferation, their preparation and use
06/07/1995EP0656062A1 Dorsal tissue affecting factor and compositions
1 ... 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 ... 1494